Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - CAPITAL EXPENDITURES
Capital Expenditures ANAB - AnaptysBio, Inc.
-807 K
LAST VALUE
23.14%
2 YEAR CAGR
5.36%
5 YEAR CAGR
-36.10%
10 YEAR CAGR